3653 results for «358»
3653 results
CTO PCI
19 Dec 2024 – From GulfPCR-GIM 2024
Embark on a journey to master Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) procedures. This comprehensive session will prepare your mindset, equip you with strategies to avoid failure, and provide valuable insights from real-world CTO case failures. Explore techniques to effectively deal with CTO procedure...
Femoropopliteal intervention
18 Dec 2024 – From GulfPCR-GIM 2024
This session provides an in-depth look at femoropopliteal intervention, covering the updated PAD guidelines, step-by-step approaches for peripheral interventions based on clinical scenarios, the essential toolbox for performing femoropopliteal endovascular procedures, and effective techniques for managing wide bore femoral access complications. Gain comprehensive insights to optimize...
Left main PCI strategies for bifurcations and trifurcations
19 Dec 2024 – From GulfPCR-GIM 2024
Explore this comprehensive session on left main PCI strategies for bifurcations and trifurcations. Discover techniques such as the triple kissing balloon inflation technique in a complex distal LM trifurcation lesion, imaging-guided multivessel PCI to left anterior descending CTO and left main bifurcation, and IVUS-guided PCI to...
Challenging structural interventions #1
18 Dec 2024 – From GulfPCR-GIM 2024
Prepare to be captivated by a collection of challenging structural interventions showcased in this session. Witness the ingenuity of interventional cardiologists as they tackle complex cases, from TMVR with laceration of the anterior mitral leaflet to percutaneous closure of sinus of Valsalva aneurysm rupture. Discover how...
Caught between a calcified rock and a hard place
19 Dec 2024 – From GulfPCR-GIM 2024
This session delves into the challenges of managing heavily calcified coronary lesions, particularly in complex scenarios like left main bifurcation angioplasty and in elderly patients with unstable angina. Explore innovative techniques to tackle abrupt vessel closure, situations where rotablation may fall short, and state-of-the-art approaches for...
Complications and challenging cases #2
19 Dec 2024 – From GulfPCR-GIM 2024
Dive into this session to explore a collection of challenging cases and complications encountered in interventional cardiology. From a ruptured balloon inside a coronary artery to a percutaneous ventricular septal rupture closure post myocardial infarction, uncover the strategies and techniques used to manage these complex situations....
Aortic valve disease – Imaging strategies for optimal valve selection and outcomes in TAVI
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
Dive into this in-depth session on aortic valve disease, covering essential imaging insights for selecting the ideal TAVI prosthesis, identifying risk markers for pacemaker implantation, and optimizing outcomes in complex cases. Learn how multi-modality imaging aids in diagnosing and managing bioprosthetic valve dysfunction, including detecting patient-prosthesis...
Navigating complexities in multivalvular heart disease: risk stratification, intervention timing, and advanced imaging
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session explores the challenges of managing mixed and multiple valvular heart diseases, focusing on risk stratification, treatment decisions, and transcatheter intervention timing. Experts discuss assessing and treating aortic and mitral paravalvular leaks, as well as managing mitral annular calcification, using case studies to guide optimal...
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
